Frantz Viral Therapeutics
7740 Metric Drive,
Mentor, 44060, OH,
United States
Mentor, 44060, OH,
United States
1 440-255-1155
Life Sciences
Frantz Viral Therapeutics Technographics
Frantz Viral Therapeutics Software Purchases and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Frantz Viral Therapeutics and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 10 Frantz Viral Therapeutics employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Frantz Viral Therapeutics has purchased the following applications: Jeeva eClinical Cloud for Clinical Trial Management in 2022, Jeeva TeleVisits for Collaboration in 2024, Jeeva EDC Software for Intelligent Document Processing in 2022 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Frantz Viral Therapeutics is running and its propensity to invest more and deepen its relationship with Jeeva Clinical Trials , Automattic , Tiny Technologies or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Frantz Viral Therapeutics revenues, which have grown to $1.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Frantz Viral Therapeutics intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Frantz Viral Therapeutics Data, Technology Stack, and Enterprise Applications
ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Jeeva Clinical Trials | Legacy | Jeeva eClinical Cloud | Clinical Trial Management | ERP Services and Operations | n/a | 2022 | 2022 |
In 2022, Frantz Viral Therapeutics implemented Jeeva eClinical Cloud as its Clinical Trial Management platform to run a multi site Phase 2 oncology study focused on anal HSIL across sites in the United States. The deployment centralized EDC, eConsent, and patient engagement into a single cloud instance to provide unified study records and sponsor access for ongoing trial oversight.
The implementation leveraged Jeeva eClinical Cloud with inferred usage of CTMS, EDC, and eConsent modules to consolidate site data capture, monitoring workflows, and electronic consent processes. Configuration centered on study level forms, role based access controls, and amendment propagation mechanisms consistent with Clinical Trial Management functionality, supporting coordinated site activity and investigator documentation.
Operational coverage included clinical operations, site management, regulatory documentation, and patient engagement functions, with rollout to participating US investigational sites and sponsor study teams. Governance incorporated centralized protocol amendment controls and change propagation workflows, enabling rapid protocol amendment implementations as described in vendor case materials.
|
|
|
|
|
Clinical Trial Management | ERP Services and Operations |
|
2023 | 2023 |
|
Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Jeeva Clinical Trials | Legacy | Jeeva TeleVisits | Collaboration | Collaboration | n/a | 2024 | 2024 |
In 2024, Frantz Viral Therapeutics centralized clinical operations on Jeeva Clinical Trials, deploying Jeeva EDC/CTMS to manage multi-site Phase II cancer-prevention trials in the United States. The deployment included Jeeva TeleVisits as the remote patient engagement and video visits component, with Jeeva TeleVisits aligned to the platform's documented patient engagement and remote-visit capabilities, and categorized under Collaboration.
The implementation focused on EDC and CTMS capabilities, with explicit use of Jeeva EDC/CTMS for study configuration, electronic data capture, and trial management workflows across participating sites. Functional scope included standardized study configuration and centralized data workflows, and the solution’s patient engagement module was used to support remote visit scheduling and virtual encounter capture.
Operational coverage was the clinical operations function for multi-site Phase II cancer-prevention trials in the United States, impacting study coordination, data management, and patient engagement processes. Governance emphasis centered on centralizing configuration and standardizing data workflows across sites, which improved study configuration and data workflows as reported.
|
Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Jeeva Clinical Trials | Legacy | Jeeva EDC Software | Intelligent Document Processing | Content Management | n/a | 2022 | 2022 |
In 2022, Frantz Viral Therapeutics selected Jeeva EDC Software as part of Jeeva's eClinical platform to execute a multi-site Phase 2 clinical trial for HPV-associated anal HSIL. The implementation centralized eConsent and data capture across US sites and focused on Jeeva EDC Software capabilities categorized as Intelligent Document Processing.
Configuration work emphasized EDC case report form design, electronic consent workflows, and CTMS study planning and site management capabilities within Jeeva EDC Software. Standard EDC activities inferred from the vendor release, such as metadata-driven CRF build, query management, role based access controls, and electronic source documentation workflows, were configured to align clinical operations with remote monitoring needs.
Operational scope extended to clinical operations, site coordinators, study monitors, and regulatory oversight across participating US sites, with the platform used for enrollment tracking and centralized data aggregation. The source material does not specify external system integrations, so initial data orchestration and document processing remained within Jeeva's eClinical platform during the estimated go live.
The selection and publication occurred in 2022, with an estimated go live the same year. Governance changes included updates to standard operating procedures for eConsent and site onboarding, and adjustments to monitoring and data review workflows to reflect centralized electronic capture. The deployment was undertaken to improve recruitment and study operations across US sites, leveraging Jeeva EDC Software Intelligent Document Processing capabilities for clinical data capture and consent management.
|
|
|
|
|
Web Content Management | Content Management |
|
2026 | 2026 |
|
|
|
|
|
Web Content Management | Content Management |
|
2025 | 2025 |
|
CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Tag Management | CRM |
|
2020 | 2020 |
|
PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Apps Development | PaaS |
|
2020 | 2020 |
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2022 | 2022 |
|
|
|
|
|
Domain Name System (DNS) | IaaS |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Frantz Viral Therapeutics
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Frantz Viral Therapeutics Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Frantz Viral Therapeutics Technographics
Frantz Viral Therapeutics is a Life Sciences organization based in United States,
with around 10 employees and annual revenues of $1.0 million.
Frantz Viral Therapeutics operates a diverse technology stack with applications such as
Jeeva eClinical Cloud, Jeeva TeleVisits and Jeeva EDC Software,
covering areas like Clinical Trial Management, Collaboration and Intelligent Document Processing.
Frantz Viral Therapeutics has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Jeeva Clinical Trials.
Frantz Viral Therapeutics recently adopted applications including
WordPress in 2026, TinyMCE in 2025 and Jeeva TeleVisits in 2024,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Frantz Viral Therapeutics’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Frantz Viral Therapeutics’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Frantz Viral Therapeutics technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.